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Intramuscular hemangioma is a relatively rare, benign tumor of vascular origin, accounting for less than 1% of all hemangiomas.
This paper reports a case of a 48-year-old female patient with intramuscular hemangioma in the upper lip, treated with
sclerotherapy and subsequent complementary surgery.
1.Introduction
Hemangiomas are benign vascular alterations characterized
by the proliferation of blood vessels, commonly occurring
in subcutaneous and submucous tissue [1–6]. When located
superﬁcially, a hemangioma is easy to diagnosis. However,
in the relatively uncommon occurrence deeper in the tissue,
hemangioma is often diﬃcult to diagnose [7–11].
When the proliferation of blood vessels is found between
skeletal muscle ﬁbers, such tumors are denominated intra-
muscular hemangioma (IMH), which accounts for less than
1% of all hemangiomas [5]. IMHs occur more frequently on
the trunk and extremities as well as in the head and neck
region, which account for 10 to 20% of all IMHs [3–6]. The
diagnosis of IMH is determined through biopsy following
the sudden growth of the tumor [3, 6]. The predominant
complaint is the presence of a frequently painful, slow-
growingnodulewithanegativeestheticeﬀect[3].IMHshave
no predilection for either gender [5].
Given the rarity, deep location, and variable clinical pre-
sentation of these tumors [5], the aim of the present study
was to describe a clinical case of IMH in the upper lip treated
with intratumor administration of monoethanolamine
oleate and subsequent surgery.
2. Case Presentation
A 48-year-old female patient came to the stomatology
service complaining of swelling in the upper lip. The patient
history revealed that the lesion was asymptomatic, with
evolution of approximately four years without treatment.
The extraoral exam revealed asymmetry between the upper
and lower lips. The intraoral exam revealed a submucous
nodule coated with normal mucous, with ﬁrm consistency
to the touch as well as clear limits and mobility. The
initial diagnostic hypotheses were ﬁbroma, pleomorphic
adenoma, and neurilemmoma. Following incisional biopsy,
the histopathologic exam revealed the proliferation of2 Case Reports in Dentistry
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Figure 1: Capillaries (stars) invading muscle tissue (arrows; 200x,
HE).
Figure 2: Proliferation of capillaries (400x, HE).
vascular capillaries invading the muscle tissue (Figure 1),
leading to the diagnosis of capillary hemangioma (Figure 2).
The treatment selected was a series of applications of 5%
Ethamolin (Zest farmacˆ eutica, Rio de janeiro, RJ, Brazil)
diluted in distilled water (1:1) for a ﬁnal concentration of
2.5%. After three applications, the patient did not return to
the clinic for three years after the initial biopsy (Figure 3).
As there was partial total regression of the lesion, excisional
biopsy of the submucous nodule was performed (Figure 4).
The histopathologic exam revealed the proliferation of
vascular capillaries, with the presence of a perivascular
hyaline material in the muscle tissue (Figure 5), leading to
the diagnosis of intramuscular hemangioma (IMH). The
patient has since been in followup and has shown no signs
of recurrence or any other changes associated to the injury.
3. Discussion
Clinically, the diﬀerential diagnosis of submucous heman-
gioma includes cyst, mucocele, and Kaposi’s sarcoma. The
vitropressure maneuver makes a hemangioma acquire a pale
coloration and reduce in size due to the emptying of its
blood vessels [12–14]. This procedure was not carried out
in the case reported here, as the lesion was not located
superﬁcially and did not exhibit the typical purplish color
Figure 3: Clinical aspect of submucous nodule following scle-
rotherapy.
Figure 4: Excisional biopsy.
of a hemangioma. Thus, the hypotheses initially raised were
ﬁbroma, pleomorphic adenoma, and neurilemmoma, rather
than hemangioma [15].
The slow growth with an evolution of four years
indicated a likely benign nature of the tumor. Kanaya et al.
[5] reported the presence of painful tumefaction in the right
cheek of a 14-year-old patient since the child was three years
of age, with a gradual increase in size and the diagnosis of
IMH of the masseter muscle.
In the present case, the patient had not undergone any
type of treatment since the perception of the ﬁrst indications
of the nodule and only sought treatment for esthetic reasons.
Aﬀected patients generally seek treatment due to esthetic or
functional problems [16]. Surgical excision resulted in the
functional and esthetic resolution of six cases reported by
Ranero-Ju´ arez et al. [16]. This is the ﬁrst treatment choice
in patients with systemic alterations, signiﬁcant deformities,
or refractory lesions stemming from other treatments.
In the case reported here, the tumor was located in the
orbicular muscle of the upper lip, with a nodular appearance
and absence of pain symptoms. However, such tumors may
b ea c c o m p a n i e db yp a i n[ 8, 17–19]. According to Nam and
Hwang [6], the occurrence of IMH in an oral orbicular mus-
cle is rare. In the head and neck region, IMH is mainly found
in the masseter, trapezium, periorbital, sternocleidomastoid,
or oral orbicular muscles. The involvement of adjacent
structures may include the parotid gland, pterygoid muscles,
or infratemporal fossa [3]. Despite the broad anatomicCase Reports in Dentistry 3
Figure 5: Proliferation of capillaries with hyaline perivascular
material (arrows; 400x, HE).
distribution, however, IMH most commonly occurs in the
extremities [8, 17–19].
In the present case, the initial conduct was incisional
biopsy of the tumor for diagnostic purposes. Bleeding was
easily controlled during the procedure. The histopathologic
analysis revealed the proliferation of capillaries invading the
muscle tissue. There was also the proliferation of endothelial
cells due to increased mitotic activity, with the accumulation
of thin-walled capillaries separated by sparse conjunctive
tissue stroma. The diagnosis was determined as capillary
hemangioma [14, 20, 21].
The treatment selected was sclerotherapy. However,
before choosing the adequate type of treatment for a heman-
gioma, a number of characteristics should be considered,
such as duration, size, location and number of tumors,
patient age, and the hemodynamics of the tumor. Moreover,
the viability of the intended technique must also be assessed
[22].
Sclerotherapy with monoethanolamine oleate was cho-
sen due to its safety and ease of application and the fact
that the treatment could be repeated without risk in the case
of recurrence of the nodule [23]. Through an intratumor
injection, monoethanolamine oleate either completely or
partially reduces the size of the tumor so that surgical
excision can be performed with a greater degree of safety.
Causing the safe involution of the tumor through a nonsur-
gical procedure and favoring both the postoperative period
and patient esthetics are important factors to be considered
in the decision as to what treatment to employ [24].
Monoethanolamine oleate initially irritates the venous
or capillary epithelium, thereby producing an extra-vascular
inﬂammatory response, which results in ﬁbrosis and the
occlusion of the blood vessels [25]. This agent also causes
tissue necrosis and the formation of local thromboses,
observed 24 hours following application [21, 25, 26]. The
patient in the present case only reported slight discomfort
during and following the administration of the sclerosing
agent. The postoperative pain may be explained by the
induction of a local inﬂammatory response due to the
intratumor injection of the agent. Pain symptoms, however,
should not extend for more than three days [21, 26].
It should be borne in mind that an injection of a
volume greater than the recommended amount can cause
extensive tissue necrosis and trigger an anaphylactic reaction
in patients who are sensitive to the drug [27]. Moreover,
the application should always be carried out in the center
and deepest portion of the tumor in order to avoid tissue
necrosis. This care was taken during the application of the
sclerosing agent in the present case. Moreover, the substance
was diluted, resulting in a lesser concentration [21]i na n
eﬀort to minimize tissue necrosis.
Sclerotherapy and surgery are the most often employed
techniques in the treatment of hemangiomas of the mouth
[14]. Surgery can be employed in the form of embolization,
selective arterial ligation, or simple exeresis with or without
plastic reconstruction [22, 28, 29]. According to Odabasi
et al. [3], the most indicated treatment for IMH is surgical
removal with a margin of safety due to the inﬁltrative nature
of the tumor; the nonaﬀected portion of the muscle beyond
the limits of the tumor should also be removed in order to
avoid local recurrence.
After three sessions of sclerotherapy, the patient did not
appear for followup and only returned three years after
the biopsy. Due to the residual presence of the tumor,
the decision was made for the surgical removal of the
submucous nodule, establishing the diagnosis of capillary
IMH, with the proliferation of capillaries and the presence
of hyaline perivascular material intercalated in the muscle
tissue. The surgery was used as a complementary treatment
to sclerotherapy. However, if the patient had shown up for
the remaining scheduled sessions for the administration of
thesclerosingagent,theremayhavebeennoneedforsurgery.
The patient is currently in followup, with no clinical
signs of recurrence or any other condition associated to
the tumor. Although local recurrence may occur in more
than 50% of cases, it has no correlation with the type of
predominant vessel or anatomic location of the tumor and
there are no reports of malignant transformation in cases
of incomplete removal [7, 30]. Kanaya et al. [5]r e p o r t e d
a case of recurrence nine months following conservative
surgery of an IMH in the masseter muscle. In an additional
surgical approach, the authors removed a portion of the
buccalbranchofthefacialnerveinordertoachievecomplete
resection of the tumor. According to Odabasi et al. [3], the
intraoral approach in such cases oﬀers limited exposure of
the branches of the facial nerve, which may result in nerve
injury and postoperative paralysis; therefore, an extraoral
approach is required. As the tumor in the case reported
here was well circumscribed and well delimited due to the
ﬁbrosis in the region caused by sclerotherapy, there were no
diﬃculties in the execution of its complete excision.
4. Conclusion
It is important for dentists to know that diascopy is of
considerable assistance to the correct diagnosis of superﬁcial
vascular lesions. However, when such tumors are located
more deeply in the tissue, a biopsy is essential to the
diagnosis. Moreover, one must take into consideration the
correct indication of sclerosing agents for treatment.4 Case Reports in Dentistry
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